4Z8-67180-67370
5 vaccinations
2 coded responses
31 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 530 / WI
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
- 2021-01-13
- 2021-01-18
- 2021-01-19
- 2021-01-22
- 2021-01-27
-
2021-02-03
Dose 2 — Pfizer-BioNTech
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-02-24
-
2021-03-04
Survey response — day 28, dose 2MedDRA: Arthralgia, Axillary pain, Chest pain, Fatigue, Lymph node pain, Lymphadenopathy, Musculoskeletal pain, Neck pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Lymphadenopathy & pain culminating in 3 days of severe pain from neck, through right scapula, into shoulder joint/upper chest & armpit, accompanied by fatigue. Note, pain is on opposite side from injection site. Symptoms resolving, but still residualMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-17
-
2021-05-05
Survey response — 3 months, dose 2MedDRA: Dizziness, Emergency care, Office visit, Vertigo — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Sudden dizziness & vertigo started 3/30/21. It has recurred every few days, lasting from a few minutes to over 8 hours, in varying intensities. · Healthcare visit (other): Follow-up to ER with NP.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-05
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-05
-
2021-10-13
Dose 3 — Pfizer-BioNTech
- 2022-01-12
- 2022-02-03
- 2022-04-15
-
2022-05-18
Dose 4 — Pfizer-BioNTech
- 2022-06-29
- 2022-08-17
-
2022-10-20
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-16
- 2022-11-16
- 2022-11-17
- 2022-11-25
- 2022-12-01
- 2023-01-19
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech | |
| 3 | 2021-10-13 | Pfizer-BioNTech | No |
| 4 | 2022-05-18 | Pfizer-BioNTech | No |
| 5 | 2022-10-20 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 5 — day 28, dose 2
Symptoms: Lymphadenopathy & pain culminating in 3 days of severe pain from neck, through right scapula, into shoulder joint/upper chest & armpit, accompanied by fatigue. Note, pain is on opposite side from injection site. Symptoms resolving, but still residual cut off by CDC
Release 8 — 3 months, dose 2
Symptoms: Sudden dizziness & vertigo started 3/30/21. It has recurred every few days, lasting from a few minutes to over 8 hours, in varying intensities.
Healthcare visit (other): Follow-up to ER with NP.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | ✓ | ✓ | ✓ |
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Axillary pain | ✓ | ✓ | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Lymph node pain | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Musculoskeletal pain | ✓ | ✓ | ✓ |
| SD | Neck pain | ✓ | ✓ | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release